Zura Bio Ltd (ZURA)
About Zura Bio Ltd
Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$68.7M
- Total assets
- $113.9M
- Market cap
- $322.6M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $75.2M
- Operating income
- -$75.2M
- Net income
- -$68.7M
- EPS (basic)
- $-1.06
- EPS (diluted)
- $-1.06
Balance sheet
- Total assets
- $113.9M
- Current assets
- $112.3M
- Total liabilities
- $12.4M
- Current liabilities
- $12.4M
- Shareholders’ equity
- $101.5M
Cash flow
- Operating cash flow
- -$64.8M
- Investing cash flow
- -$113.0K
- Financing cash flow
- -$2.2M
- Net cash flow
- -$67.1M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $322.6M
- EPS (diluted)
- $-1.06
- Shares outstanding
- 61.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Mar 21, 2023
Zura Bio Ltd (ZURA) Stock Price
- Reported a net loss of $68.7M.
- Trading 26% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Zura Bio Ltd.
Write a review
News about Zura Bio Ltd
News & sentiment via Polygon.io
Zura Bio Ltd: frequently asked questions
Is Zura Bio Ltd an American company?
Zura Bio Ltd is a US-based company headquartered in La Jolla, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Zura Bio Ltd headquartered?
Zura Bio Ltd is headquartered in La Jolla, California, United States.
Is Zura Bio Ltd publicly traded?
Yes — Zura Bio Ltd is a publicly traded company. Its stock trades under the ticker symbol ZURA on the NASDAQ.
What does Zura Bio Ltd do?
Zura Bio Ltd is an American Pharmaceuticals company in the Health & Beauty sector.
